Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-17

Clinical Trial Update: Evaluating Iron Protein Succinylate Oral Solution in Treating Chronic Heart Failure and Iron Deficiency [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Iron Protein Succinylate Oral Solution for chronic heart failure with iron deficiency; the study status is currently unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Iron Protein Succinylate Oral Solution (Iron protein succinylate oral solution)

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: Chronic Heart Failure, Iron-deficiency | Phase 4 | Status: UNKNOWN